Clinical Trials: better participation and more efficiency through connectivity

01 March 2016
Report type: Application Spotlight
Author(s): Andy Castonguay, Jonathan Tee - Associate Principal Analyst
Categories: Clinical Trials
Keywords: Clinical trials, diagnostic trials, electronic source record, IoT, Internet of Things, M2M, machine-to-machine, prevention trials, quality of life trials, remote monitoring, screening trials, supportive care trials, treatment trials
Companies: Apple, BioClinica, Clinical Ink, Collain Healthcare, Entra Health, LG CNS Healthcare Solutions, MC-10, Sage Bionetworks
Number of Pages: 7

The clinical trials application comprises the use of dedicated connected devices to support field trials of medical procedures, treatments and drugs. Through remote monitoring solutions, clinical trial administrators are able to extend trials more effectively outside of expensive dedicated testing facilities and into the homes of trial volunteers. We include a number of different types of trials within this application, specifically: treatment, prevention, diagnostic, screening and quality of life/supportive care.

This Application Spotlight provides a qualitative and quantitative analysis of the M2M market related to Clinical Trials. It provides a definition, description, analysis of drivers and barrier, and high level forecasts for growth in connections, technology split and revenue opportunity.

For a full set of country-by-country forecasts, refer to the IoT Forecast Database.

Keywords: Clinical trials, diagnostic trials, electronic source record, IoT, Internet of Things, M2M, machine-to-machine, prevention trials, quality of life trials, remote monitoring, screening trials, supportive care trials, treatment trials

Companies covered in this report: Apple, BioClinica, Clinical Ink, Collain Healthcare, Entra Health, LG CNS Healthcare Solutions, MC-10, Sage Bionetworks

7 pages

Download PDF > Log in or subscribe to this Research Stream, please see our Advisory Service.
quick links >